About Cytochrome c oxidase assembly factor SCO1
Cytochrome c oxidase assembly factor SCO1 (SCO1) is a protein
from Homo sapiens identified by UniProt accession
O75880, 301 residues long.
MolForge cross-references it against 0 known binders and
51 disease associations.
Target properties
| Protein name | Cytochrome c oxidase assembly factor SCO1 |
| UniProt accession | O75880 |
| Gene | SCO1 |
| Organism | Homo sapiens |
| Length | 301 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (51)
Diseases linked to this target (Open Targets).
- mitochondrial complex 4 deficiency, nuclear type 4 · score 0.73
- neurodegenerative disease · score 0.48
- cytochrome-c oxidase deficiency disease · score 0.46
- mitochondrial complex IV deficiency, nuclear type 22 · score 0.42
- leigh syndrome due to mitochondrial complex iv deficiency · score 0.42
- mitochondrial disease · score 0.37
- fatal infantile encephalocardiomyopathy · score 0.37
- Leigh syndrome · score 0.19
- genetic disorder · score 0.19
- lung adenocarcinoma · score 0.18
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O75880-F1 | alphafold | PREDICTED | 77.77 | — |
Amino-acid sequence (301 residues)
MAMLVLVPGR VMRPLGGQLW RFLPRGLEFW GPAEGTARVL LRQFCARQAE AWRASGRPGY CLGTRPLSTA RPPPPWSQKG PGDSTRPSKP GPVSWKSLAI TFAIGGALLA GMKHVKKEKA EKLEKERQRH IGKPLLGGPF SLTTHTGERK TDKDYLGQWL LIYFGFTHCP DVCPEELEKM IQVVDEIDSI TTLPDLTPLF ISIDPERDTK EAIANYVKEF SPKLVGLTGT REEVDQVARA YRVYYSPGPK DEDEDYIVDH TIIMYLIGPD GEFLDYFGQN KRKGEIAASI ATHMRPYRKK S
Explore Cytochrome c oxidase assembly factor SCO1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets